Brief: Active Biotech Q2 Operating Loss Of SEK 11.3 MLN
Aug 21 (Reuters) - Active Biotech AB publ ACTI.ST: Q2 OPERATING LOSS AT SEK 11.3 MLN Source text: ID:nMFN4TGDvY Further company coverage: ACTI.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))